AMG 510_Ph3 NSCLC Monotherapy Comparator Trial
Research payments
$3,275,499
Through program year 2021, $3,275,499 in research payments was reported against AMG 510_Ph3 NSCLC Monotherapy Comparator Trial, across 290 payments, paid by Amgen Inc..
- Paid by
- Amgen Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $2,357,746 | 122 |
| 2020 | Research | $917,753 | 168 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ferdinandos Skoulidis Houston, TX Named on 8 payments
- Yuanbin Chen Grand Rapids, MI Named on 7 payments
- Viralkumar Bhanderi Tallahassee, FL Named on 7 payments
- George Keogh Charleston, SC Named on 6 payments
- Karen Kelly Sacramento, CA Named on 6 payments
- Syed Karim Independence, MO Named on 6 payments
- Anjan Patel Sarasota, FL Named on 6 payments
- Balazs Halmos Cleveland, OH Named on 5 payments
- Brian Hunis Aventura, FL Named on 5 payments
- Jamal Misleh Newark, DE Named on 5 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.